Cambridge Investment Research Advisors’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-53,482
| Closed | -$2.27M | – | 3468 |
|
|
2024
Q3 | $2.27M | Buy |
53,482
+5,616
| +12% | +$238K | 0.01% | 1256 |
|
|
2024
Q2 | $2.45M | Buy |
47,866
+44,555
| +1,346% | +$2.28M | 0.01% | 1153 |
|
|
2024
Q1 | $207K | Sell |
3,311
-4,936
| -60% | -$309K | ﹤0.01% | 2999 |
|
|
2023
Q4 | $618K | Sell |
8,247
-49,966
| -86% | -$3.74M | ﹤0.01% | 2017 |
|
|
2023
Q3 | $4.96M | Buy |
58,213
+54,171
| +1,340% | +$4.61M | 0.02% | 653 |
|
|
2023
Q2 | $441K | Buy |
4,042
+93
| +2% | +$10.1K | ﹤0.01% | 2229 |
|
|
2023
Q1 | $328K | Sell |
3,949
-259
| -6% | -$21.5K | ﹤0.01% | 2408 |
|
|
2022
Q4 | $433K | Buy |
4,208
+1,893
| +82% | +$195K | ﹤0.01% | 2132 |
|
|
2022
Q3 | $245K | Buy |
2,315
+253
| +12% | +$26.8K | ﹤0.01% | 2537 |
|
|
2022
Q2 | $226K | Sell |
2,062
-1,809
| -47% | -$198K | ﹤0.01% | 2615 |
|
|
2022
Q1 | $404K | Buy |
+3,871
| New | +$404K | ﹤0.01% | 2283 |
|
|
2021
Q4 | – | Sell |
-15,219
| Closed | -$1.75M | – | 3167 |
|
|
2021
Q3 | $1.75M | Buy |
15,219
+8,118
| +114% | +$931K | 0.01% | 1175 |
|
|
2021
Q2 | $689K | Sell |
7,101
-16,362
| -70% | -$1.59M | ﹤0.01% | 1806 |
|
|
2021
Q1 | $1.73M | Buy |
23,463
+9,939
| +73% | +$732K | 0.01% | 1084 |
|
|
2020
Q4 | $923K | Buy |
+13,524
| New | +$923K | 0.01% | 1360 |
|
|
2019
Q2 | – | Sell |
-15,375
| Closed | -$724K | – | 2207 |
|
|
2019
Q1 | $724K | Buy |
15,375
+10,570
| +220% | +$498K | 0.01% | 1237 |
|
|
2018
Q4 | $272K | Sell |
4,805
-320
| -6% | -$18.1K | ﹤0.01% | 1717 |
|
|
2018
Q3 | $280K | Sell |
5,125
-13,749
| -73% | -$751K | ﹤0.01% | 1835 |
|
|
2018
Q2 | $1.11M | Buy |
18,874
+350
| +2% | +$20.5K | 0.01% | 922 |
|
|
2018
Q1 | $1.05M | Buy |
18,524
+13,101
| +242% | +$743K | 0.01% | 913 |
|
|
2017
Q4 | $267K | Buy |
+5,423
| New | +$267K | ﹤0.01% | 1733 |
|